NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 16 Nov 2026, 06:17 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Manipal Health Enterprises Limited · MANIPALHOS
✦ AI Summary▲ PositiveResults
Manipal Health Enterprises Limited has informed the Exchange about the transcript of the Earnings call that was organized with the Analysts and Investors on Friday, November 13, 2026 pertaining to Un-audited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Manipal Health Enterprises Limited has informed the Exchange about Transcript
Attachments (1)
📄pdf
Download →
9632000477_16112026181343_Signed_Transcript_-_InvestorMeet.pdf
View document text
Date: November 16, 2026
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers,
Bandra Kurla Complex, Bandra (E), Dalal Street,
Mumbai – 400 051 Mumbai - 400001.
NSE Scrip Symbol: MANIPALHOS BSE Scrip Code: 544847
Subject: Transcript of the Earnings call with Analysts/ Investor
Dear Sir/Ma’am,
Pursuant to Regulation 30 and 46 read with Schedule III of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we are enclosing herewith the transcript of the Earnings call that was
organized with the Analysts and Investors on Friday, November 13, 2026 pertaining to Un-audited
Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended
September 30, 2026 and the same can be accessed at: https://www.manipalhospitals.com/mhel-financial-
reports#investor-earnings-call
This intimation is being submitted for your information and records.
Thank you.
For Manipal Health Enterprises Limited
(formerly Manipal Health Enterprises Private Limited)
Sathish K R
Company Secretary and Compliance Officer
Membership No.: A15203
MHE-Public
“Manipal Health Enterprises Limited
Q2 FY27 Earnings Conference Call”
November 13, 2026
MANAGEMENT: MR. DILIP JOSE – MANAGING DIRECTOR AND CHIEF
EXECUTIVE OFFICER – MANIPAL HEALTH
ENTERPRISES LIMITED
MR. SAMEER AGARWAL – GROUP CHIEF FINANCIAL
OFFICER – MANIPAL HEALTH ENTERPRISES LIMITED
MR. KARTHIK RAJAGOPAL – CHIEF OPERATING
OFFICER – MANIPAL HEALTH ENTERPRISES LIMITED
MR. PARAG AGARWAL – HEAD, BUSINESS FINANCE,
FINANCIAL PLANNING & ANALYSIS, AND CAPTIVE
FINANCE SHARED SERVICES – MANIPAL HEALTH
ENTERPRISES LIMITED
MODERATOR: MR. DIWAKAR PINGLE – ERNST & YOUNG
Page 1 of 19
Manipal Health Enterprises Limited
November 13, 2026
Moderator: Ladies and gentlemen, good day and welcome to Manipal Health Enterprises Q2 FY27
Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode,
and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call, please signal an operator by pressing
star and then zero on your touchtone phone. Please note, this conference is being recorded.
I now hand the conference over to Mr. Diwakar Pingle from Ernst & Young. Thank you, and
over to you, sir.
Diwakar Pingle: Thanks, Sagar. Good evening to all the participants in this call. Before we proceed on the call,
let me remind you that the discussion may contain forward-looking statements that may
involve known and unknown risks, uncertainties, and other factors. It must be viewed in
conjunction with our business risks that could cause future results, performance, or
achievement to differ significantly from what is expressed or implied by such forward-looking
statements.
Please note, while we mailed the results to you, given the outlook issued today, maybe a few of
you have still not received it. In case it still doesn't reach your mailbox, please do let us know,
and we'll make all attempt to send it out. However, it's also available on the website and in the
exchanges also, so you should be able to see the results there.
To take us through the results and answer your questions today, we have the top management
of Manipal Health Enterprises Limited, represented by Mr. Dilip Jose, MD and CEO; Mr.
Sameer Agarwal, Group CFO, and Mr. Karthik Rajagopal, COO, and other members of the
management. We will start the call with a brief overview about the company and on the quarter
gone past, and then conduct the Q&A session.
With that said, let me hand over the call to Dilip Jose. Over to you, Dilip.
Dilip Jose: Thank you, Diwakar. Good evening and welcome to our Quarter 2 Earnings Call. Along with
me are my senior colleagues, Sameer Agarwal, our CFO, and Karthik Rajagopal, our Chief
Operating Officer. I hope you have had a chance to go through the presentation that outlines
the robust performance that we have had in quarter 2.
In fact, quarter 2 is the best ever quarter that we have had so far in our history. Before we take
your questions, I would like to take a few minutes just to headline the performance in the
quarter as well as H1 to give you more context as we look ahead to the rest of the financial
year.
First of all, we are pleased that our growth continued to be driven by volumes, more patients
accessing our care during this quarter also, as we believe that's the most sustainable option for
growth in the hospital system. Our Q2 revenue of about INR3,400 crores is a growth of over
37% from Q2 of last year. Our quarter 2 EBITDA was INR882 crores, which is an increase of
Page 2 of 19
Manipal Health Enterprises Limited
November 13, 2026
about 30% over Q2 of FY26. Our EBITDA margin, excluding Sahyadri, was 27%, and at the
network level, which includes Sahyadri, it was 26% for the quarter.
As I mentioned earlier, we had a volume-led growth this quarter as well. Inpatient volumes
increased by about 35% and outpatient volumes by 27% year-on-year. Average occupancy
across the network was 70% during the quarter compared to 65% in the first quarter of this
year.
That is, we had 65% occupancy in quarter 1 FY27, which has now grown to 70% in the quarter
2 in the same year. This is despite maintaining an industry-leading length of stay of only 2.8
days. Excluding Sahyadri, our average revenue per occupied bed per day is at about
INR77,000 in quarter 2, which is a growth of over 8% versus last year. At a network level, the
ARPOB per day is about INR70,600 per day.
While that completes a quick financial highlight of the quarter 2 performance, let me also give
you a brief update on our first half. Our revenue of INR6,490 crores is a growth of about 38%
over last year. Our network EBITDA stood at INR1,631 crores, up by 28% year-on-year.
Our EBITDA margin, excluding Sahyadri, was 26%, and at the network level, including
Sahyadri, it is 25% for the first half. Our PAT is INR639 crores, which is a margin of about
10%. Digital revenue contributed to nearly 23% of our overall revenue in the first half of
FY27.
Out-of-hospital care offerings include e-pharmacy process about 34,000 orders across 26
hospitals in four metros. Telehealth solutions completed over 38,000 virtual consultations, and
chatbot, including the Manipal AI, our AI-enabled digital health companion, handled about
24,000 interactions during the first half of this year.
Our centers of excellence, that is managing high-acuity care in cardiology, oncology,
neurology, gastroenterology, orthopedics, and renal sciences, which we sort of in a short form
call CONGO-R, continued to grow robustly, with their revenue contribution was 64.2% in the
first half of this year. Oncology, neurology, and orthopedics have led this growth, along with
other specialties, growing by about 43%.
We also continued our efforts to further strengthen these specialties with investments. To share
a couple of examples, in the recent month, just a few days ago, we installed world's latest Da
Vinci 5 robotic surgical system at our hospital in Dwarka in Delhi, introduced a clinically
governed two-wheeler fleet of first responder service in Bangalore city, a first ever for private
hospital emergency response in the state.
Our hospital in Patiala became the first in the city to introduce advanced robotic-assisted
orthopedic surgery. I would also like to highlight some of the outstanding clinical
achievements, including the first ever and regional first milestones.
Page 3 of 19
Manipal Health Enterprises Limited
November 13, 2026
Our Dhakuria Hospital in Kolkata performed first-of-its-kind laser-guided renal artery
angioplasty in Eastern India. Our recently launched Greenfield Hospital at Electronic City in
Bangalore performed South India's first reported 5-ALA fluorescence-guided surgery for a
brain tumor on a 61-year-old patient. Our Goa Hospital performed the state's first covered self-
expandable metallic stent procedure to treat criti
[Showing first 8,000 characters — download PDF for full document]